This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Eosinophilic leukaemia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Eosinophilic leukaemia is characterised by an excess of immature eosinophil precursors in the blood or marrow.

It is ultimately fatal but patients may be relieved by corticosteroids, vincristine or hydroxycarbamide (former British Approved Name, hydroxyurea).


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page